Pilar Mendoza
Overview
Explore the profile of Pilar Mendoza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
3622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hortal A, Villanueva A, Arellano I, Prieto C, Mendoza P, Bustelo X, et al.
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136362
B-cell chronic lymphocytic leukemia (B-CLL) is the most common type of leukemia in the Western world. Mutation in different genes, such as and , and deletions at specific chromosomic regions,...
2.
Martinez-Riano A, Delgado P, Tercero R, Barrero S, Mendoza P, Oeste C, et al.
Commun Biol
. 2023 Apr;
6(1):437.
PMID: 37081131
Successful vaccines rely on activating a functional humoral immune response through the generation of class-switched high affinity immunoglobulins (Igs). The germinal center (GC) reaction is crucial for this process, in...
3.
Hortal A, Oeste C, Cifuentes C, Alcoceba M, Fernandez-Pisonero I, Clavain L, et al.
Mol Cancer
. 2022 Feb;
21(1):35.
PMID: 35120522
Background: Chronic lymphocytic leukemia (CLL) is the most frequent, and still incurable, form of leukemia in the Western World. It is widely accepted that cancer results from an evolutionary process...
4.
Cho A, Muecksch F, Schaefer-Babajew D, Wang Z, Finkin S, Gaebler C, et al.
Nature
. 2021 Oct;
600(7889):517-522.
PMID: 34619745
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B cell responses that continue to evolve for at least a year. During that time, memory B cells express increasingly broad...
5.
Breton G, Mendoza P, Hagglof T, Oliveira T, Schaefer-Babajew D, Gaebler C, et al.
J Exp Med
. 2021 Feb;
218(4).
PMID: 33533915
SARS-CoV-2 is responsible for an ongoing pandemic that has affected millions of individuals around the globe. To gain further understanding of the immune response in recovered individuals, we measured T...
6.
Gaebler C, Wang Z, Lorenzi J, Muecksch F, Finkin S, Tokuyama M, et al.
Nature
. 2021 Jan;
591(7851):639-644.
PMID: 33461210
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected 78 million individuals and is responsible for over 1.7 million deaths to date. Infection is associated with the development of variable...
7.
Breton G, Mendoza P, Hagglof T, Oliveira T, Schaefer-Babajew D, Gaebler C, et al.
bioRxiv
. 2020 Dec;
PMID: 33330867
Summary: We show that SARS-CoV-2 infection elicits broadly reactive and highly functional memory T cell responses that persist 6 months after infection. In addition, recovered individuals show enduring immune alterations...
8.
Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Primary African Isolates
Lorenzi J, Mendoza P, Cohen Y, Nogueira L, Lavine C, Sapiente J, et al.
J Virol
. 2020 Dec;
95(5).
PMID: 33298542
Novel therapeutic and preventive strategies are needed to contain the HIV-1 epidemic. Broadly neutralizing human antibodies (bNAbs) with exceptional activity against HIV-1 are currently being tested in HIV-1 prevention trials....
9.
Mendoza P, Lorenzi J, Gaebler C
Curr Opin HIV AIDS
. 2020 Nov;
16(1):25-35.
PMID: 33229949
Purpose Of Review: The coronavirus disease 2019 (COVID-19) pandemic has caught the world unprepared, with no prevention or treatment strategies in place. In addition to the efforts to develop an...
10.
Gaebler C, Wang Z, Lorenzi J, Muecksch F, Finkin S, Tokuyama M, et al.
bioRxiv
. 2020 Nov;
PMID: 33173867
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected 78 million individuals and is responsible for over 1.7 million deaths to date. Infection is associated with development of variable levels of...